Investors are suing Hims & Hers Health, a telehealth and personal care company, alleging that the company and its executives made false or misleading statements to the public about the company's business, financial performance, or prospects. Plaintiffs claim that when the truth about these misstatements came to light, the company's stock price dropped significantly, causing financial harm to shareholders. The proposed class consists of investors who purchased or acquired Hims & Hers Health securities during a specific period when the allegedly misleading statements were being made. This is a securities fraud case, not a traditional consumer product lawsuit, meaning the people seeking compensation are shareholders rather than customers who bought the company's health and wellness products.
The case is in its earliest stage. The defendant has not yet responded. Class certification — the court's decision on whether the case can proceed as a class action — typically takes 12 to 24 months after filing.
Source: CourtListener docket entry. This summary was generated automatically and may not reflect subsequent filings.
A participating attorney may be able to evaluate your claim at no cost to you.